ArticleJournal of materials science. Materials in medicine2014
Olive oil based novel thermo-reversible emulsion hydrogels for controlled delivery applications.
Article in Journal of materials science. Materials in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 64 citations in OpenAlex.
- Enhanced Oil Binding Potential ofPolymers · 2025Article
- Formulation and Characterization of Emulgel-Based Jelly Candy: A Preliminary Study on Nutraceutical Delivery.Gels (Basel, Switzerland) · 2023Article
- Novel Formulation of Bigel-Based Vegetable Oil Spreads Enriched with Lingonberry Pomace.Foods (Basel, Switzerland) · 2022Article
- Interfacial and Bulk Stabilization of Oil/Water System: A Novel Synergistic Approach.Nanomaterials (Basel, Switzerland) · 2020Article
- A facile fabrication of porous fluoro-polymer with excellent mechanical properties based on high internal phase emulsion templating using PLA as co-stabilizer.RSC advances · 2019Article
- Novel oleogel formulation based on amaranth oil: Physicochemical characterization.Food science & nutrition · 2019Article
- Enzymatic synthesis and self-assembly of glycolipids: robust self-healing and wound closure performance of assembled soft materials.RSC advances · 2018Article
- Genipin-Crosslinked Gelatin-Based Emulgels: an Insight into the Thermal, Mechanical, and Electrical Studies.AAPS PharmSciTech · 2015Article
- Development and characterization of sorbitan monostearate and sesame oil-based organogels for topical delivery of antimicrobials.AAPS PharmSciTech · 2015Article
- Characterization of gelatin-agar based phase separated hydrogel, emulgel and bigel: a comparative study.Journal of materials science. Materials in medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gels have been considered as a popular mode of delivering medicament for the treatment of sexually transmitted diseases (STDs) (e.g. human immunodeficiency virus, bacterial vaginosis, epididymitis, human papillomavirus infection and condylomata acuminata etc.). The present study discusses the development of novel olive oil based emulsion hydrogels (EHs) using sorbitan monopalmitate as the structuring agent. The developed EHs may be tried as drug delivery vehicle for the treatment of STDs. The formation of EHs was confirmed by fluorescence and confocal microscopy. FTIR studies suggested intermolecular hydrogen bonding amongst the components of the EHs. X-ray diffraction study suggested the amorphous nature of the EHs. The developed EHs have shown non-Newtonian flow behavior. The EHs were found to be biocompatible. The formulations were able to effectively deliver two model antimicrobial drugs (e.g. ciprofloxacin and metronidazole), commonly used in the treatment of the STDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.